Skip to content

Home
IOncology
Infectious Desease Frontier
IHepatology
Hematology Frontier
Conference topics
Experts Interviews
Informations
Live Broadcasting
Logout

Connecting Medical Expertise through Media

Search for:

Home
IOncology
Infectious Disease Frontier
International Hepatology
Hematology Frontier
Conference topics
Experts’ Interviews
Informations

Home
IOncology
Infectious Disease Frontier
International Hepatology
Hematology Frontier
Conference topics
Experts’ Interviews
Informations

Search for:

Posted inHematology Frontier

Prof. Harry Paul Erba: Focusing on Precision Therapy for FLT3-Mutated AML and Exploring Resistance Management and MRD-Guided Strategies

Posted by

By Ailiyaer Ainiwaer（Elyar Anwar） 2026.11.12Posted inHematology Frontier0 Shares

Home » Prof. Harry Paul Erba: Focusing on Precision Therapy for FLT3-Mutated AML and Exploring Resistance Management and MRD-Guided Strategies

YouTube player

Views: 37

Share via:

Facebook
X (Twitter)
LinkedIn
More

Ailiyaer Ainiwaer（Elyar Anwar）

Post navigation

Previous Post

ESMO 2026 | Professor Wei Xu: From Tumor Shrinkage to Surgery—Exploring a New Neoadjuvant Treatment Strategy for Head and Neck Squamous Cell Carcinoma with Iparomlimab, Tovoricimab, and Chemotherapy

ESMO 2026 | Professor Wei Xu: From Tumor Shrinkage to Surgery—Exploring a New Neoadjuvant Treatment Strategy for Head and Neck Squamous Cell Carcinoma with Iparomlimab, Tovoricimab, and Chemotherapy

Next Post

2026 IFSC | Professor Daichi Inoue Explores Clonal Evolution in Leukemia with Extremely Poor Prognosis: SETBP1 Abundance-Dependent Mechanisms and Early Intervention Strategies

LinkedIn
Twitter
Mail

Related Media:

Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
Paris, France

Facebook
X (Twitter)
LinkedIn
More Networks

Share via

Copy link

CopyCopied